Monitoring blood sugar levels in people starting pancreatic cancer treatment
Part of Cancer, Digestive system, Hormones & metabolism clinical trials.
This study looks at how well blood sugar (glucose) levels can be monitored and managed in people with pancreatic cancer who are starting their first treatment. It aims to understand if careful glucose management can improve well-being and possibly treatment outcomes.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have a diagnosis of pancreatic adenocarcinoma (the most common type of pancreatic cancer).
- You must be about to start your first chemotherapy or other systemic treatment for this cancer.
- You must be 18 years or older.
- You must be generally able to take care of yourself (doctors call this 'performance status').
- Your key blood counts and kidney/liver function must meet minimum levels, as checked by your doctor.
- You must not have type 1 diabetes, and if you have type 2 diabetes, you must not already be under the regular care of a diabetes specialist.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at blood tests to find markers that may help detect and monitor pancreatic cancer. It compares people with pancreatic cancer to those with benign pancreatic conditions and healthy volunteers.
This study uses small pancreatic cancer samples grown in the lab to understand which treatments may work best for people with pancreatic cancer. It may help researchers better “profile” tumors so standard care can be matched to the most effective options.
This study is testing a new blood test to find pancreatic cancer early. It looks for tiny bits of cancer DNA floating in your blood, which could help catch the disease before symptoms start.
This trial tests whether giving extra diabetes medication along with standard chemotherapy can help control blood sugar and improve outcomes in people with pancreatic cancer that has spread. It may help you manage diabetes better during treatment.
This study looks at how blood sugar levels and gut bacteria relate to pancreatic problems, including cysts, inflammation, and cancer. By joining, you help researchers understand these connections better, which could lead to new ways to treat or manage these conditions.
This trial is for people who had surgery for pancreatic cancer and are now deciding on maintenance therapy. A special blood test (ctDNA) may help doctors choose the best follow-up treatment to prevent the cancer from coming back.
Hear when a new Pancreatic cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.